Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
JAKAFI®
ruxolitinib (tablets)
PERSERIS™
(risperidone) for extended-release injectable suspension
ZULRESSO™
(brexanolone) injection CIV
You are here
Home
Drug Forecast
Aliskiren (Tekturna), A Novel Antihypertensive Approach to Inhibition of the Renin– Angiotensin–Aldosterone System
Julie Cromer, PharmD, and Simona Peker, BS, MS/MLS, MSA, PharmD
PDF version:
Download PDF
Authors Cromer and Peker review aliskiren (Tekturna) for hypertension.
P T. 2008;33(2)
: 92